Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Ioannis Fouzas"'
Autor:
Ioannis Fouzas, Anna-Bettina Haidich, Chrysoula Pipili, Nikolaos Antoniadis, Evangelos Cholongitas, Argyro Koukoufiki, Ioannis Goulis
Publikováno v:
Indian Journal of Gastroenterology. 38:348-355
As the mortality rates after liver transplantation (LT) have been reduced, the attention has shifted to additional conditions which still compromise the quality of life and the survival of these patients, such as the post-LT metabolic syndrome (MS).
Autor:
Anastasia Prodromidou, Ioannis D. Kostakis, Ioannis Fouzas, Paraskevas Stamopoulos, Nikolaos Machairas, Georgios C. Sotiropoulos, Zoe Garoufalia
Publikováno v:
Transplantation Proceedings. 51:433-436
Introduction Repeat liver resection (RLR) has been adopted by surgeons as the first-line treatment in the case of intrahepatic recurrence of hepatocellular carcinoma (HCC), whereas salvage liver transplantation (SLT) is considered a second-line optio
Autor:
Ioannis Fouzas, A. Tranda, Nikolaos Antoniadis, F. Solonaki, G. Miserlis, G. Imvrios, A. Zolota
Publikováno v:
Transplantation Proceedings. 50:3386-3391
Introduction New-onset diabetes after transplantation (NODAT) is a complication of renal transplantation (RT) with an adverse effect on graft survival. Objectives The purpose of the present study was to compare modifiable or non-modifiable clinical a
Autor:
Nikolaos Antoniadis, T. Deligiannidis, A. Tranta, G. Miserlis, A. Papagiannis, K. Karakasi, V. Papanikolaou, Georgios Katsanos, A. Zolota, A. Fouza, Ioannis Fouzas, C. Nikolaidou, N. Salveridis, C. Papadimitriou, F. Solonaki
Publikováno v:
Transplantation proceedings. 52(10)
Despite great improvements in the short-term patient and kidney graft survival, the long-term morbidity and mortality in kidney transplant recipients still remains a significant problem. The aim of the study was to evaluate the impact of both donor a
Autor:
Ioannis Fouzas, S. Vernadakis, Gernot M. Kaiser, Jürgen Treckmann, Georgios C. Sotiropoulos, Nikolaos Machairas, Andreas Paul
Publikováno v:
Transplantation proceedings. 51(2)
Introduction Organ procurement from deceased donors has been steadily augmented over the last 20 years. With a more aged donor population, a higher incidence of intraabdominal pathologies, including abdominal aortic aneurysms and atherosclerotic aort
Autor:
Ioannis Fouzas, Maria Daoudaki
Publikováno v:
Transplantation proceedings. 51(2)
Autor:
Nikolaos Antoniadis, E. Mouloudi, Georgios Katsanos, V. Papanikolaou, Ioannis Fouzas, S. Vasileiadou, N. Salveridis, G. Imvrios, C. Papanikolaou, A. Fouza, K. Karakasi
Publikováno v:
Transplantation proceedings. 51(2)
Variations of the anatomy of donor hepatic arteries increase the number of arterial anastomoses during liver transplantation and, possibly, the incidence of hepatic artery thrombosis (HAT). In this study, we describe the arterial anatomic variations
Autor:
Jeremias Wohlschlaeger, Georgios C. Sotiropoulos, Ioannis Fouzas, Nikolaos Machairas, S. Vernadakis, Andreas Paul
Publikováno v:
Transplantation proceedings. 51(2)
Introduction Hepatocellular carcinoma (HCC) in cirrhosis is a widely accepted indication for liver transplantation (LT). Many scoring systems have been proposed intending to an extension of the established Milan criteria. Bridging treatments are syst
Autor:
Georgios C. Sotiropoulos, Zoe Garoufalia, Ioannis Fouzas, Nikolaos Machairas, Ioannis D. Kostakis, Nikolaos Zavras, Anastasia Prodromidou, Paraskevas Stamopoulos
Publikováno v:
Transplantation proceedings. 51(2)
Wilson's disease (WD) is a rare autosomal recessive disorder transmitted through a gene located on chromosome 13. Liver transplantation (LT) provides a therapeutic option for patients with WD presenting fulminant liver failure or drug resistance. LT
Autor:
Evangelos Akriviadis, Olga Giouleme, Ioannis Goulis, E. Mouloudi, Nikolaos Antoniadis, Eleni Theocharidou, G. Ιmvrios, D. Filis, Ioannis Fouzas, Evangelos Cholongitas
Publikováno v:
Transplantation proceedings. 51(2)
Everolimus, a mammalian target of rapamycin inhibitor, may have a protective role on hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT), but data regarding the impact of its trough serum levels on HCC recurrence are missing.Fi